切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (02) : 133 -138. doi: 10.3877/cma.j.issn.2095-3232.2021.02.004

所属专题: 综述 文献

专家论坛

肝门部胆管癌外科治疗进展和争议
陈泰安1, 熊永福2, 杨发才2, 李梦2, 黄徐建2, 李敬东1,()   
  1. 1. 637000 四川省南充市,川北医学院附属医院肝胆外一科;637000 四川省南充市,川北医学院肝胆胰肠研究所
    2. 637000 四川省南充市,川北医学院附属医院肝胆外一科
  • 收稿日期:2021-01-19 出版日期:2021-04-10
  • 通信作者: 李敬东
  • 基金资助:
    四川省教育厅创新团队项目(16TDD0025); 四川省科技厅项目(19YYJC1298)

Research progress and dispute on surgical treatments for intrahepatic cholangiocarcinoma

Taianm Chen1, Yongfu Xiong2, Facai Yang2   

  • Received:2021-01-19 Published:2021-04-10
引用本文:

陈泰安, 熊永福, 杨发才, 李梦, 黄徐建, 李敬东. 肝门部胆管癌外科治疗进展和争议[J/OL]. 中华肝脏外科手术学电子杂志, 2021, 10(02): 133-138.

Taianm Chen, Yongfu Xiong, Facai Yang. Research progress and dispute on surgical treatments for intrahepatic cholangiocarcinoma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(02): 133-138.

[1]
de Jong MC, Marques H, Clary BM, et al. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases[J]. Cancer, 2012, 118(19):4737-4747.
[2]
Nassour I, Mokdad AA, Porembka MR, et al. Adjuvant therapy is associated with improved survival in resected perihilar cholangiocarcinoma: a propensity matched study[J]. Ann Surg Oncol, 2018, 25(5):1193-1201.
[3]
Liu CL, Fan ST, Lo CM, et al. Improved operative and survival outcomes of surgical treatment for hilarcholangiocarcinoma[J]. Br J Surg, 2006, 93(12):1488-1494.
[4]
Lee SG, Song GW, Hwang S, et al. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience[J].J Hepatobiliary Pancreat Sci, 2010, 17(4):476-489.
[5]
Chen RX, Li CX, Luo CH, et al. Surgical strategies for the treatment of Bismuth type Ⅰ and Ⅱ hilar cholangiocarcinoma: bile duct resection with or without hepatectomy?[J]. Ann Surg Oncol, 2020, 27(9):3374-3382.
[6]
Chen XP, Lau WY, Huang ZY, et al. Extent of liver resection for hilar cholangiocarcinoma[J]. Br J Surg, 2009, 96(10):1167-1175.
[7]
Ikeyama T, Nagino M, Oda K, et al. Surgical approach to bismuth type Ⅰ and Ⅱ hilar cholangiocarcinomas: audit of 54 consecutive cases[J]. Ann Surg, 2007, 246(6):1052-1057.
[8]
Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portalvein embolization[J]. Ann Surg, 2003, 238(1):84-92.
[9]
Sugiura T, Okamura Y, Ito T, et al. Left hepatectomy with combined resection and reconstruction of right hepatic artery for Bismuth type Ⅰ and Ⅱ perihilar cholangiocarcinoma.[J]. World J Surg, 2019, 43(3): 894-901.
[10]
Lee Y, Choi D, Han S, et al. Comparison analysis of left-side versus right-side resection in bismuth type Ⅲ hilar cholangiocarcinoma[J]. Ann Hepatobiliary Pancreat Surg, 2018, 22(4):350-358.
[11]
Ebata T, Mizuno T, Yokoyama Y, et al. Surgical resection for Bismuth type Ⅳ perihilar cholangiocarcinoma[J]. Br J Surg, 2018, 105(7): 829-838.
[12]
Matsumoto N, Ebata T, Yokoyama Y, et al. Role of anatomical right hepatic trisectionectomy for perihilar cholangiocarcinoma[J]. Br J Surg, 2014, 101(3):261-268.
[13]
Zaydfudim VM, Rosen CB, Nagorney DM. Hilar cholangiocarcinoma[J]. Surg Oncol Clin N Am, 2014, 23(2):247-263.
[14]
Dumitrascu T, Brasoveanu V, Stroescu C, et al. Major hepatectomies for perihilar cholangiocarcinoma: predictors for clinically relevant postoperative complications using the International Study Group of Liver Surgery definitions[J]. Asian J Surg, 2016, 39(2):81-89.
[15]
Bhutiani N, Scoggins CR, McMasters KM, et al. The impact of caudate lobe resection on margin status and outcomes in patientswith hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium[J]. Surgery, 2018, 163(4):726-731.
[16]
Juntermanns B, Kaiser GM, Reis H, et al. Long-term survival after resection for perihilar cholangiocarcinoma: impact of UICC staging and surgical procedure[J]. Turk J Gastroenterol, 2019, 30(5):454-460.
[17]
Chen W, Ke K, Chen YL. Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis[J]. Eur J Surg Oncol, 2014, 40(5):489-495.
[18]
Schimizzi GV, Jin LX, Davidson 4th JT, et al. Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium[J]. HPB, 2018, 20(4): 332-339.
[19]
Hemming AW, Mekeel K, Khanna A, et al. Portal vein resection in management of hilar cholangiocarcinoma[J]. J Am Coll Surg, 2011, 212(4):604-613.
[20]
Takahashi Y, Nagino M, Nishio H, et al. Percutaneous transhepatic biliary drainage catheter tract recurrence incholangiocarcinoma[J]. Br J Surg, 2010, 97(12):1860-1866.
[21]
Komaya K, Ebata T, Yokoyama Y, et al. Verification of the oncologic inferiority of percutaneous biliary drainage toendoscopic drainage: a propensity score matching analysis of resectable perihilar cholangiocarcinoma[J]. Surgery, 2017, 161(2):394-404.
[22]
Yamashita H, Ebata T, Yokoyama Y, et al. Pleural dissemination of cholangiocarcinoma caused by percutaneous transhepatic biliary drainage during the management of resectable cholangiocarcinoma[J]. Surgery, 2019, 165(5):912-917.
[23]
Al Mahjoub A, Menahem B, Fohlen A, et al. Preoperative biliary drainage in patients with resectable perihilar cholangiocarcinoma: is percutaneous transhepatic biliary drainage safer and more effective than endoscopic biliary drainage? a meta-analysis[J]. J Vasc Interv Radiol, 2017, 28(4):576-582.
[24]
Tang Z, Yang Y, Meng W, et al. Best option for preoperative biliary drainage in Klatskin tumor: a systematic review and meta-analysis[J]. Medicine, 2017, 96(43):e8372.
[25]
Kawashima H, Itoh A, Ohno E, et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy andrisk factors related to complications[J]. Ann Surg, 2013, 257(1): 121-127.
[26]
Kawakami H, Kuwatani M, Onodera M, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma[J].J Gastroenterol, 2011, 46(2):242-248.
[27]
Liu F, Li Y, Wei Y, et al. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? a systematic review[J]. Dig Dis Sci, 2011, 56(3):663-672.
[28]
Coelen RJS, Ruys AT, Besselink MGH, et al. Diagnostic accuracy of staging laparoscopy for detecting metastasized or locally advanced perihilar cholangiocarcinoma: a systematic review and meta-analysis[J]. Surg Endosc, 2016, 30(10):4163-4173.
[29]
Bird N, Elmasry M, Jones R, et al. Role of staging laparoscopy in the stratification of patients with perihilar cholangiocarcinoma[J]. Br J Surg, 2017, 104(4):418-425.
[30]
Hu H, Wu Z, Jin Y, et al. Minimally invasive surgery for hilar cholangiocarcinoma: state of art and future perspectives[J]. ANZ J Surg, 2019, 89(5):476-480.
[31]
Lin E, Sarmiento JM. Laparoscopic extended right hepatectomy, portal lymphadenectomy, and hepaticojejunostomy for hilar cholangiocarcinoma[J]. J Laparoendosc Adv Surg Tech A, 2014, 24(6):411-416.
[32]
腹腔镜肝门部胆管癌根治切除术操作规范专家组,中华外科杂志编辑部. 腹腔镜肝门部胆管癌根治性切除操作流程专家建议[J]. 中华外科杂志,2019,57(8):561-567.
[33]
Sudan D, DeRoover A, Chinnakotla S, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma[J]. Am J Transplant, 2002, 2(8):774-779.
[34]
Ethun CG, Lopez-Aguiar AG, Anderson DJ, et al. Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease[J]. Ann Surg, 2018, 267(5):797-805.
[35]
Moris D, Kostakis ID, Machairas N, et al. Comparison between liver transplantation and resection for hilar cholangiocarcinoma:a systematic review and meta-analysis[J]. PLoS One, 2019, 14(7): e220527.
[36]
Hong JC, Jones CM, Duffy JP, et al. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma[J]. Arch Surg, 2011, 146(6):683-689.
[37]
Dondorf F, Uteß F, Fahrner R, et al. Liver transplant for perihilar cholangiocarcinoma (Klatskin tumor): the essential role of patient selection[J]. Exp Clin Transplant, 2019, 17(3):363-369.
[1] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[2] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[7] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[10] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[11] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[12] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[13] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[14] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[15] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?